Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / ISHARES BIOTECH
-
Total 13F shares
-
38,516,647
-
Share change
-
-1,648,953
-
Total reported value
-
$4,710,098,168
-
Put/Call ratio
-
388%
-
Price per share
-
$122.29
-
Number of holders
-
828
-
Value change
-
-$206,156,929
-
Number of buys
-
222
-
Number of sells
-
392
Institutional Holders of ISHARES TR - ISHARES BIOTECH (IBB) as of Q3 2023
As of 30 Sep 2023,
ISHARES TR - ISHARES BIOTECH (IBB) was held by
828 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
38,516,647 shares.
The largest 10 holders included
BANK OF AMERICA CORP /DE/, MORGAN STANLEY, GOLDMAN SACHS GROUP INC, CITIGROUP INC, JPMORGAN CHASE & CO, UBS Group AG, BNP PARIBAS ARBITRAGE, SNC, Royal Bank of Canada, COMMERCE BANK, and WELLS FARGO & COMPANY/MN.
This page lists
830
institutional shareholders reporting positions in this security
for the Q3 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.